Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model


Tas A., Koklu S., Beyazit Y., Karaca G., Astarci H. M. , Akbal E., ...Daha Fazla

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, cilt.35, ss.549-553, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 35
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1016/j.clinre.2011.02.013
  • Dergi Adı: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
  • Sayfa Sayıları: ss.549-553

Özet

Aim: Percutaneous ethanol injection is an established management of nonresectable hepatocellular carcinoma (HCC) because of its high effectiveness and minimal invasiveness. However, ethanol has many disadvantages like less anti-tumoral necrotic effectivity, unequal permeation and local diffusion. The aim of this study is to compare hepatic tissue effects of percutaneous Ankaferd Blood Stopper (ABS) injection in comparison to ethanol in rat liver tissue.